GEHCGE HealthCare Technologies Inc.
AI adoption · Q1 2026 earnings call
Health CareScaling
9
extracted from this call
4 / 5
quantified with specifics
Not disclosed
no breakout in this call
AI was discussed primarily as an embedded capability within GEHC's new product portfolio, with management framing AI algorithms as a key differentiator driving higher pricing and margin improvement on specific devices such as the Vivid Pioneer ultrasound system. Management also highlighted AI-powered workflow solutions receiving FDA clearance in MR, and articulated a longer-term vision of SaaS-based AI applications deployable across imaging fleets, supported by the Intelerad acquisition. Quantification of AI's standalone revenue contribution was not provided, though management cited margin improvement of 'multiple hundred basis points' on AI-embedded products.
Adopter
See full leaderboard →60/ 100
78
stage: scaling · max spec: 4
40
1 quant outcome
65
2 scopes
product_embeddedproduct_standalone
9 AI mentions from this call.
Extracted verbatim from the GEHC Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T4Q&A· CEO· Product-embedded AIwhen you think about AI-enabled platforms, you have Intelerad in there, it's coming in as a Software-as-a-Service model, but we count 7 AI-enabled assets across the portfolio at this point, various different programs. So will it all show up as Software-as-a-Service? What are the milestones we should look for, for AI-enabled capabilities? What does the economic model look like over time?
“Relative to AI, it comes in 2 flavors today. One is it's the AI inside. It's why things like Vivid Pioneer are growing at a very high rate right now because of 4, 5 algorithms that make this product better than its competition. So we get a higher price for it. We get multiple hundred points -- basis points improvement in margin, which is a combination of its cost, but it's really about its value.”
— Peter Arduini, GEHC earnings callVivid Pioneer - T3Q&A· CEO· Standalone AI productwhen you think about AI-enabled platforms, you have Intelerad in there, it's coming in as a Software-as-a-Service model, but we count 7 AI-enabled assets across the portfolio at this point, various different programs. So will it all show up as Software-as-a-Service? What are the milestones we should look for, for AI-enabled capabilities? What does the economic model look like over time?
“The other part you hit on, which is, again, we're doing more and more, which is actually having SaaS-based capabilities for specific features. So part of our vision is to be able to sell the hardware, have it more standardized of what that feature set is and then have a wide menu of other SaaS cloud-enabled applications that customers can customize by that individual scanner or by their fleet. And so CT is kind of our first modality as well as ultrasound that leads in that.”
— Peter Arduini, GEHC earnings callIntelerad - T3Q&A· CEO· Product-embedded AIwhen you think about AI-enabled platforms, you have Intelerad in there, it's coming in as a Software-as-a-Service model, but we count 7 AI-enabled assets across the portfolio at this point, various different programs. So will it all show up as Software-as-a-Service? What are the milestones we should look for, for AI-enabled capabilities? What does the economic model look like over time?
“Back to Intelerad, why is that important? Because not only in outpatient, but an inpatient, the more that we integrate those tools, that will be the reading interface, not only for the diagnosis, but also, in many cases, deploying the AI tools.”
— Peter Arduini, GEHC earnings callIntelerad - T3Prepared remarks· CEO· Product-embedded AI
“the future of imaging heavily hangs towards MRI. It's radiation-free, very friendly for children, older adults and the technology with things like air recon DL are moving from where it used to be 45, 50 minute exams down to 10 to 15.”
— Peter Arduini, GEHC earnings callAir Recon DL - T3Prepared remarks· CEO· Product-embedded AI
“we received multiple FDA clearances for next-generation technologies, including a new 3T and reduced Helium platform and state-of-the-art AI-powered workflow solution.”
— Peter Arduini, GEHC earnings callAI-powered workflow solution - T3Q&A· CEO· Product-embedded AIwhen you think about AI-enabled platforms, you have Intelerad in there, it's coming in as a Software-as-a-Service model, but we count 7 AI-enabled assets across the portfolio at this point, various different programs. So will it all show up as Software-as-a-Service? What are the milestones we should look for, for AI-enabled capabilities? What does the economic model look like over time?
“All of those products that I had on the page in the deck all have embedded AI. Some of them have a couple of algorithms. Some of them had 4 or 5.”
— Peter Arduini, GEHC earnings call - T3Prepared remarks· CEO· Product-embedded AI
“all of these innovations are differentiated because of a unique design or AI capabilities and have higher margins than our predicate products.”
— Peter Arduini, GEHC earnings call - T2Prepared remarks· CEO· Product-embedded AI
“also are big believers that artificial intelligence breakthroughs are also going to change traditional CT. So we have a list of different things that are going to be coming out that are going to increase resolution and capabilities in our traditional CT range and will be significantly more cost-effective for someone who wants more resolution and maybe going to Photon Counting.”
— Peter Arduini, GEHC earnings callPhotonova Spectra - T2Prepared remarks· CEO· Product-embedded AI
“We're excited about the opportunity to grow our AI, cloud and software capabilities, leveraging our Intelerad platform.”
— Peter Arduini, GEHC earnings callIntelerad
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- Management did not disclose total AI-related revenue or ARR, despite analyst question (Mizuho/Anthony Petrone) directly asking about AI-enabled platform economics.
- No specific quantification of how many AI algorithms are embedded across the full NPI portfolio beyond a qualitative reference to '4 or 5 algorithms' on Vivid Pioneer.
- No disclosure of R&D spend specifically allocated to AI development.
- The 'multiple hundred basis points' margin improvement attributed to AI-embedded products was not tied to a specific product line revenue figure or period.
- No timeline or revenue target provided for the SaaS/cloud AI application layer beyond a directional statement.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.